Abstract:Background: Protein phosphotylation is one of the essential steps in cell signaling, and aberrant phosphorylation is a common event in human cancer. The expression of receptor type protein tyrosine phosphatase gamma (PTPRG) in normal breast is found to be similar to 50-60% higher than that of breast tumor tissue. Overexpression of PTPRG inhibits anchorage-independent growth and proliferation of breast cancer cells. To understand the tumor suppression characteristics of PTPRG, we studied its tumor suppressive function in an athymic mouse model and evaluated factors that can potentially regulate its expression in breast cancer cells. Materials and Methods: To investigate the function of PTPRG in vivo, athymic nude mice were implanted with MCF-7 cells overexpressing PTPRG. For in vitro study, protein levels of cell cycle regulators, cell cycle re-entry, and the phosphorylation levels of extracellular signal-regulated protein kinases 112 (ERKI/2) were examined. In addition, methylation assays were conducted to investigate the epigenetic modification on the promoter of PTPRG. Results: Athymic nude mice bearing MCF-7 cells overexpressing PTPRG showed a reduction in tumor burden in comparison to animals implanted with MCF-7 cells transfected with vector alone. When these two cell lines were studied in an in vitro system, elevated mRNA and protein levels of cell cycle regulators, p21(cip) and p27(kip) were detected in MCF-7 cells overexpressing PTPRG compared to cells transfected with vector alone. Similarly, overexpression of PTPRG also delayed the re-entry of breast cancer cells into the cell cycle after serum starvation, and reduced the phosphorylation levels ERK1/2 in MCF-7 cells. In addition, methylation assays in PTPRG promoter in breast cancer cell lines (including SK-Br-3) revealed an aberrant methylation pattern. When SK-Br-3 and MCF-7 cells were treated with deoxy-5-azacytidine (DAC) and trichostatin A (TSA), these compounds reactivated the expression of PTPRG, suggesting an epigenetic control on its expression. Conclusion: Our results indicated that PTPRG inhibited breast tumor formation in vivo; PTPRG may up-regulate p21(cip) and p27(kip) proteins through the ERK1/2 pathway. This study also showed methylation-mediated silencing of PTPRG in breast cancer cell lines. These data indicate that PTPRG exhibits the characteristics of a breast tumor suppressor.

Skp2 Regulates Subcellular Localization Of Ppar. By Mek Signaling Pathways In Human Breast Cancer

Cytoplasmic Skp2 Expression Is Increased In Human Melanoma And Correlated With Patient Survival

Identification of Spindle and Kinetochore-Associated Family Genes As Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment

SKP2 Promotes Breast Cancer Tumorigenesis and Radiation Tolerance Through PDCD4 Ubiquitination.

High Skp2/Low P57kip2 Expression is Associated with Poor Prognosis in Human Breast Carcinoma

Cytoplasmic Skp2 Expression is Associated with P-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas

Function and Regulatory Mechanisms of the Candidate Tumor Suppressor Receptor Protein Tyrosine Phosphatase Gamma (PTPRG) in Breast Cancer Cells.

High Skp2/Low p57 Expression is Associated with Poor Prognosis in Human Breast Carcinoma

Ppar Gamma And Wnt/Beta-Catenin Pathway In Human Breast Cancer: Expression Pattern, Molecular Interaction And Clinical/Prognostic Correlations

Significance of Skp2 Expression in Human Gastric Carcinoma and the Relationship Between Skp2, P27 and PTEN Expression

Effects of Skp2 on the Biologic Properties of Tumors and Its Use As a Prognostic Marker and a Theraputic Target

Skp2-mediated Ubiquitination and Mitochondrial Localization of Akt Drive Tumor Growth and Chemoresistance to Cisplatin.

The Expression and Significance of P27kip1, Skp2 in Breast Cancer

The prognostic value of Skp 2 expression level in cancer : a meta-analysis

Acetylation-Dependent Regulation of Skp2 Function

Skp2–MacroH2A1–CDK8 Axis Orchestrates G2/M Transition and Tumorigenesis

SHP2 Promotes Proliferation of Breast Cancer Cells Through Regulating Cyclin D1 Stability Via the PI3K/AKT/GSK3β Signaling Pathway

Expression and Clinical Significance of PPARγ in Different Molecular Subtypes of Breast Cancer

Tyrosine Phosphatase Shp2 Mediates The Estrogen Biological Action In Breast Cancer Via Interaction With The Estrogen Extranuclear Receptor

SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma.

The Skp2 Pathway: A Critical Target for Cancer Therapy